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Literature Review 
Abstract 
 The rise in obesity numbers worldwide have led to an increase in associated co morbidities 
and consequently to a rise in the direct and indirect costs to society. For these reasons it is essential 
to treat obese and overweight individuals and to prevent the emergence of new cases. However, 
one of the most widely used approaches for the treatment of obesity, the daily calorie restriction 
diets, have been shown to be ineffective due to low adherence,  becoming urgent to find new 
methods for control and treat this multifactorial disease. Therefore, intermittent fasting approaches 
have gained popularity because they have been shown to be effective in reducing body weight and 
body fat, while preserving lean tissue and, as such, have been seen as a solution to the replacement 
of traditional daily caloric restriction diets. 
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Introduction 
 In England, a report from Health and Social Care Information Centre (2013) shows that the 
percentage of overweight and obese people increased from 57.6 % to 65.0% in men and from 48.6% 
to 58.4 % in women since 1993 until 2011. The arising in obesity numbers and consequently in the 
associated co-morbidities lead to an increase in the direct costs to the NHS  from £479.3 million in 
1998 (National Audit Office, 2001) to £4.2 billion in 2007 (UK Government’s Foresight Programme, 
2007). Additionally, the indirect costs of obesity to the economy are much higher, and have been 
calculated to had been around £18.8 billion in 2007 and estimated to reach £27 billion in 2015 (UK 
Government’s Foresight Programme, 2007). 
 In order to decrease the related health costs of this epidemic and the mortality rate 
associated with it (Pischon, et al., 2008), it is required to prevent the increase in the numbers either 
by treating overweight and obese individuals or by preventing the occurrence of new cases (Sharma, 
2007).  
 Obesity is a multifactorial health issue that combines genetic, metabolic, behavioral, 
environmental, cultural and socio-economic influences (Sharma, 2007), however, the origin of the 
problem arises from an imbalance in energy intake since body weight gain is the result of consuming 
more energy than one expends (Verduin, Agarwal, & Waltman, 2005). Due to this, interventions 
such as daily calorie restriction (DCR), which are defined as a 15 to 60% reduction in the energy 
intake required to maintain body weight (Varady, 2011), have been the most widely used strategy 
(Steyer & Ables, 2009) in order to promote a negative energy balance and, consequently, a reduction 
in total body weight (Heymsfield, et al., 2007). However, these protocols have a low efficacy 
(Heymsfield, et al., 2007) due to difficulties in adherence and compliance (Dansinger, et al., 2005; 
Del Corral, Chandler-Laney, Casazza, Gower, & Hunter, 2009; Heymsfield, et al., 2007), especially 
when food is not provided (Moreira, Most, Howard, & Ravussin, 2011), which gives rise to an urgent 
necessity of developing and adopting new and effective energy restriction protocols.  
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Daily calorie restriction and healthy eating 
 Although the interventions to prevent and treat obesity can be behavioral, pharmacological, 
surgical or environmental (Sharma, 2007), this paper will only address the behavioral component, 
more precisely the aspect of diet and energy intake.  
 As stated above, DCR approaches have been widely used to promote body weight loss but 
not always in a successful way. Heymsfield et al. (2007), in an attempt to evaluate the effectiveness 
of DCR, concluded that body weight loss achieved by the participants in weight loss studies is less 
than half of that predicted, partly due to difficulties in adherence and metabolic adaptations. As 
observed in Figure 1, if the participants were completely adherent to DCR, the reductions in body 
weight would look like the “predicted” weight loss curve rather than the weight loss curve that 
actually represents the real weigh loss (“Observed curve”). 
 
 
 
 
 
 
 
 
 
 
 
 However, failure in body weight loss studies may not just be due to lack of compliance and 
adherence from participants.  The reduced body weight loss achieved with DCR diets could be a 
consequence of a reduction in thermogenesis as a metabolic adaptation to the calorie restriction 
(Tremblay & Chaput, 2009). This means that a decrease in energy expenditure can be observed (Luke 
Figure 1: The "Observed" weight loss curve was obtained with a commercial low-caloric 
diet in the study of Stanley, James, Richard, & Frank (2003). The bars are an estimate of 
diet adherence based on the study of Dansinger, Gleason, Griffith, Selker and Schaefer 
(2005), and the “predicted” weight loss curve represents the decrease in body weight 
that should be seen if participants fully adhere to the prescribed low calorie diet. Source: 
(Heymsfield, et al., 2007) 
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& Schoeller, 1992; Redman, et al., 2009), which further exceeds the reduction predicted as a 
consequence of changes in lean tissue and fat mass and, in most cases, it is sufficient to compensate 
for energy restriction applied (Major, Doucet, Trayhurn, Astrup, & Tremblay, 2007). It was reported 
that a total body weight loss of 10% in an obese person leads to a decrease by about 8 kcal/kg  of 
lean body mass/day (Leibel, Rosenbaum, & Hirsch, 1995).  Additionally to the low effectiveness of 
the DCR diets, multiple health related institutions and/or organizations have publications regarding 
healthy eating and dieting in which it is recommend to eat small portions of food distributed in 
several meals per day. As an example, the British Nutrition Foundation (2012)  states that it is 
necessary to “restrict the amount of high energy snacks” but not ban them completely, since “it will 
make your diet more difficult to maintain”. Also, another publication from the same organization 
reports that “It is fine to snack … If you feel hungry between meals” (British Nutrition Foundation, 
2011). Furthermore, the Food Standards Agency (2007) recommend “four eating occasions, namely 
breakfast, lunch, evening meal and food consumed  between meals (snacks),” while the United 
States Department of Agriculture (n.d.) advises to “Plan for 3 meals and 1 or 2 snacks each day.”  
Therefore, it is suggested that for a healthy body weight loss and, even to achieve what is considered 
a healthy eating pattern, it is necessary and recommended to eat small amounts of food distributed 
for several meals during the day. Despite the majority of the studies being inconclusive to establish a 
relationship between meal pattern and regulation of body weight (Bellisle, McDevitt, & Prentice, 
1997; Egberts, Kymmell, Brown, Brennan, & O’Brien, 2011; La Bounty, et al., 2011; Mattson, 2005), 
some literature associates a higher meal frequency (≥5 times/day) with a lower energy intake 
(Farshchi, Taylor, & Macdonald, 2005). However, a research from Popkin and Duffey (2010) revealed 
that nowadays, the adult population consumes more 280 kcal/day in snacks and an average of 120 
kcal/day more during regular meals than 30 years ago. More recently, a study from Ohkawara, 
Cornier, Kohrt and Melanson (2013), reported that 6 meals per day, in comparison to 3 meals per 
day, have no significant effect on fat oxidation while, on the other hand, increases hunger and desire 
to eat. Therefore, it appears that, in fact, a higher meal frequency does not have a positive effect in 
reducing total energy intake during the day and, despite the lack of evidence regarding the ideal 
meal frequency, the majority of the health-care professionals and health organizations continue to 
recommend small portions of food several times per day.  
 In the last couple of years, a solution for the problems pointed out above has been proposed 
and implemented through a model that involves intermittent feeding and fasting cycles, called from 
now on as intermittent fasting (IF). A description of these interventions will be presented in further 
detail in the next chapters of this paper.  
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 A summary of the information presented above is schematically shown in Figure 2. 
 
Figure 2: Schematic representation of the problems associated with daily calorie restrictions and healthy eating patterns 
and a proposed solution to solve them 
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Intermittent Fasting 
Characterization of Intermittent Fasting approaches 
 Fasting is defined as the complete or partial abstinence from nourishment due to a variety of 
reasons, especially by medical and/or religious beliefs (Adams, et al., 1987). Therefore, intermittent 
fasting (IF) regimes are characterized by alternations between ad libitum feed and fasting periods, 
(Varady, Bhutani, Church, & Klempel, 2009). However, modified IF protocols, during which the 
consumption of 15% to 25% of daily energy requirements on fasting periods is allowed (Varady, et 
al., 2009) have also been used with the same success as true intermittent fasting approaches 
regarding reduction in fat cell size and lipolysis stimulation in mice (Varady, Roohk, Loe, McEvoy-
Hein, & Hellerstein, 2007). Also, modified IF approaches have been used in human trials as a way of 
increasing adherence and compliance (Varady & Hellerstein, 2007) during body weight loss 
programmes, and up to now, only one human trial used a true IF protocol (Heilbronn, Smith, Martin, 
Anton, & Ravussin, 2005). 
 
Why Intermittent Fasting? 
 The postulated reason for the implementation of IF regimes is that they can mimic the cycles 
of food abundance and shortage (Neel, 1962) and, consequently, the energy oscillations 
characteristics of the Paleolithic era (Halberg, et al., 2005), to which we are genetically programmed 
(Chakravarthy & Booth, 2004; Mattson, 2005; Zimmet & Thomas, 2003). This genetic adaptation was 
necessary for surviving during shortage food periods since it allowed to spare lipid and glycogen 
stores as well as lean body tissue and it is believed to be part of a thrifty genotype (Chakravarthy & 
Booth, 2004; Neel, 1962).  
 Nowadays in the western countries, there is a surplus of food availability, and the rules of a 
healthy eating pattern dictate that we should eat frequently as a way of controlling appetite 
(Speechly & Buffenstein, 1999) and managing body weight (Farshchi, et al., 2005). 
 Therefore, our eating patterns are much different from our ancestors, which is creating a 
gap between our environment and the genome to which we are programmed to (Halberg, et al., 
2005). 
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 Physiology of fasting 
After an overnight fast (~10h) all the macronutrients have been absorbed by the body 
leading to the beginning of a fasting state (Lanham-New, Mcdonald, & Roche, 2011). This state is 
characterized by a drop in glucose levels (a little under 5 mmoll/l) and a consequent decrease in 
insulin (Frayn, 2010), as represented in Figure 3 during the night time and early morning period. 
 
Figure 3: Blood glucose concentrations during the day compared with the variability of plasma insulin concentrations. 
Source: (Frayn, 2010) 
 
The decrease in insulin levels leads to an increase in glucagon secretion by the α cells of the 
pancreas in order to mobilize glycogen stores in the liver to avoid hypoglycemia when food is not 
being supplied (Lanham-New, et al., 2011; Newsholme, Leech, & Board, 2010). Thus, glucagon’s 
main function is to induce glycogen breakdown in the liver in order to produce  glucose, and to  
inhibit glycogen synthesis through activation of cyclic AMP cascade (Berg, Tymoczko, & Stryer, 2002). 
Glucose arising from glycogen breakdown in the liver is released into the bloodstream and is up 
taken by muscle and adipose tissue (Berg, et al., 2002).  Therefore, hepatic glucose output is 
regulated by the ratio of insulin to glucagon (insulin/glucagon high – glucose output suppressed; 
insulin/glucagon low – glucose output increased) (Gibney, Roche, Macdonald, & Nutrition, 2003). 
In addition, high levels of glucagon leads to a reduction in the activity of the following 
enzymes: glucokinase (GK), phosphofructokinase-1 (PFK-1) and pyruvate kinase (PK), and 
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consequently to a decrease in glycolysis rate (Roach & Benyon, 2003). Furthermore, once pyruvate 
production is decreased, due to the decrease in glycolysis rate, a consequent  reduction in Acetil-CoA 
carboxylase (ACC) activity occurs (which converts Acetyl CoA into Malonyl CoA) and therefore an 
inhibition in fatty acid synthesis occurs (Berg, et al., 2002), as represented in Figure 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additionally, the fall in blood glucose levels stimulates the secretion of epinephrine, which 
will cause the mobilization of stored glycogen and triacylglycerol, contributing to the raise in glucose 
and non-esterified fatty acids (NEFA) plasma concentrations (Gibney, et al., 2003).  
At this stage, and because the brain and the red blood cells are mainly dependent on glucose 
(Lanham-New, et al., 2011), this substrate needs to continue being produced, mainly from two 
processes: glycogenolysis (muscle glycogen stores cannot be breakdown and released into the 
bloodstream due to the absence of glucose-6-phosphatase but can contribute with lactate to be 
used by the liver for gluconeogenesis (Frayn, 2010)), and from gluconeogenesis (Konig, Bulik, & 
Holzhutter, 2012).  
Figure 4: Glucagon effects on glycolysis and lipogenesis  
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Therefore, the substrates for gluconeogenesis are lactate and  pyruvate (from red blood cells  
muscle and adipose tissue), alanine (release from muscle and adipose tissue) and glycerol (release 
from adipose tissue as a result of lipolysis) (Frayn, 2010; Gibney, et al., 2003), as exemplified in 
Figure 5. At this stage, protein breakdown is stimulated by low insulin levels and by noradrenaline 
and cortisol and noradrenaline also activates hydrolysis of triacylglycerol to release glycerol (Roach 
& Benyon, 2003). 
 
  
 
 
 
 
 
 
 
 
During the fasting state, red blood cells play an important role in the production of glucose 
through the Cori Cycle, due to the fact that they do not fully oxidize glucose, being the majority of it 
released as lactate, which allows the conversion of lactate into glucose by gluconeogenesis, as 
represented in Figure 6. The Cori cycle works in parallel with the glucose-alanine cycle, which 
converts the lactate and the amino acid, alanine, released by the muscle into glucose. 
 
 
 
 
Figure 5: Metabolism after an overnight fast. Adapted from: Frayn (2010) 
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Glucose can also be produced by protein breakdown, which provides carbon skeletons that 
can be metabolized into intermediates of the Krebs cycle and enter into gluconeogenesis (Berg, et 
al., 2002; Roach & Benyon, 2003).  
After an overnight fast, the hormone-sensitive lipase is activated due to the low levels of 
insulin, which allows the release of NEFA from adipose tissue into the bloodstream. In addition, the 
release of epinephrine also contributes to this process (Gibney, et al., 2003).  
The contribution of the gluconeogenesis and glycogenolysis  for the production of  glucose 
changes with the prolonging of the fasting period, with the gluconeogenesis assuming an increasing 
importance as the glycogen reserves become depleted (Konig, et al., 2012). The Figure 7 is a 
schematic representation of the human metabolism after an overnight fast. 
Figure 6:  Cori cycle (glucose-lactate) and Glucose-alanine cycle 
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As a way of adaptation to the further fall in blood glucose concentrations, an increase in 
lipolysis and a decrease in gluconeogenesis rate and, consequently, in protein breakdown, as a way 
of sparing muscle and attempted survival can be observed (Berg, et al., 2002; Lanham-New, et al., 
2011) (Figure 8). According to Klein, Sakurai, Romijn and Carroll (1993), this shift to the predominant 
use of lipids as substrate, appears to happen between 18 and 24 hours of fasting in young adult 
men. However, whole-body adaptations to fast periods appears to be dependent on obesity-
associated insulin resistance in women (Horowitz, Coppack, & Klein, 2001), which suggests that 
because of the higher hepatic glycogen content  in insulin-resistant obese individuals, the switching 
of to fatty acid oxidation takes much longer in these participants relative to a lean person (Muller, et 
al., 1997). 
 
 
 
Figure 7: Integration of metabolism after an overnight fast 
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Pyruvate dehydrogenase (PDH) activity, which catalyzes the irreversible conversion of 
pyruvate into acetyl-coA, is suppressed during fasting via phosphorylation of the E1 component of 
the enzyme catalyzed by pyruvate dehydrogenase kinase 4 (PDK4) (Bowker-Kinley, Davis, Wu, Harris, 
& Popov, 1998) as a way of controlling the amount of glucose that is lost through the body, and thus, 
the majority of the glucose used by tissues can be converted into lactate, pyruvate and alanine 
(Lanham-New, et al., 2011). Regarding this issue, Pilegaard, Saltin and Neufe (2003) showed a 
significant increase in PDK4 and lipoprotein lipase transcription after 20h hours of fasting, which 
suggests that short-term fasting develops an adaptive response in skeletal muscle that leads to an 
increased expression of lipid metabolism genes as a way of minimize glucose utilization.  
As a consequence of the triacylglycerols breakdown, three fatty acids and one glycerol 
becomes available to participate in other pathways, thus the glycerol portion can be converted into 
glucose by gluconeogenesis.  However, the glycerol portions become more important only after 24 
hours of fasting, when all the glucose is produced by gluconeogenesis (Jensen, Ekberg, & Landau, 
2001), becoming essential to spare protein stores (Bortz, Paul, Haff, & Holmes, 1972). In the study of 
Zauner et al. (2000), after 12 and 36 hours of fasting, the fatty acids increased from 240 ± 191 
μmol/L to 616 ± 225 μmol/L, respectively. 
Figure 8: Integration of metabolism after 18/24h of fasting 
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The oxidation of the fatty acids originates Acetyl CoA, which normally combines with 
oxaloacetate in Krebs cycle to form citrate. However, oxaloacetate is diverted to the 
gluconeogenesis pathway to produce glucose and because of that, Krebs cycle is not able to oxidize 
all of the Acetyl CoA produced, and it is converted into acetoacetate and D-3-hydroxybutyrate 
(ketone bodies), as represented in Figure 9. Ketone bodies can be used as an energy source by 
skeletal muscle, heart and brain (Finn & Dice, 2006). A study from Zauner et al. (2000) reported an 
increase in β-hydroxybutyrate in humans from 182.7 ± 262.9 μmol/L to 1949.9 ± 1458.7 μmol/L after 
12 and 36 hours of fasting, respectively. 
 
 
 
 
 
 
 
 
 
Due to low insulin levels,  skeletal muscle stops almost entirely using glucose as a fuel and 
starts to use fatty acids (Berg, et al., 2002; Frayn, 2010), which further contributes to the spare of 
lean tissue (Frayn, 2010) and for the availability of ketone bodies to be used by the brain (Roach & 
Benyon, 2003).  
In summary, it appears that IF regimes promote fat loss due to the metabolic adaptations 
that occur in the human body as a response to the absence of food supply. 
 
 
 
Figure 9: Ketone bodies formation 
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Intermittent Fasting Studies 
Overview 
 The majority of the research conducted in humans in relation to IF was done with the 
purpose of exploring the health benefits associated with it. Although the fasting practice is 
something that humans have done during the evolution period, whether due to food shortage or for 
religious reasons, the truth is that this is a very recent topic and therefore with many gaps to fill 
when it comes to scientific evidence. For this reason, uncertainties relating to the health benefits of 
this practice are still abundant but the most frequently reported are summarized in Figure 10. 
 Despite all these health benefits, they are not going to be discussed in this literature review 
as the purpose of this paper is to report changes in body composition due to IF interventions, as well 
as observed modifications in resting energy expenditure (REE) and eating patterns. 
 
 
  
 
Figure 10: Intermittent Fasting health benefits  (Hartman, et al., 1992; Safdie, et al., 2009) 
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Intermittent Fasting and Body Composition 
 The observed effects of intermittent fasting approaches regarding changes in body weight 
and body composition are summarized in Table 1. 
 
Body weight and body fat 
 In despite of being a recent topic and hence, poorly studied, scientific evidence has been 
consistent with respect to the effectiveness of IF regimes in reducing body weight and fat mass.  
 In the study of Heilbronn, Smith, Martin, Anton and Ravussin (2005), 16 (8 men and 8 
women) healthy non-obese individuals lost an average of 2.5 ± 0.5% of their baseline body weight (p 
< 0.001), from which 0.8 kg were fat mass (4 ± 1 %; p < 0.001) after 22 days of alternate day fasting 
(ADF). The study suggests that IF is feasible for short time periods in non-obese individuals and that 
the decrease in body weight reveals that participants were not consuming enough calories on the 
feasting days to maintain their body weight. 
Similar results regarding body weight loss were also reported in a short period IF 
intervention applied by Halberg et al (2005) to eight healthy young non-obese men. After two weeks 
of doing 20 hours ADF, participants lost an average of 0.9 kg in body weight (p>0.05), however they 
increased 0.3% in body fat (p>0.05). Nevertheless, it is necessary to point out that this study was not 
designed with the purpose of observing changes in body weight and/or body composition, which 
may explain the small sample size and the short duration of the intervention.  Furthermore, 
participants were instructed to eat enough food to maintain body weight. 
A longer IF intervention was applied by Johnson et al (2007) to nine obese participants, who 
followed an ADF diet protocol characterized by almost 36 hours of very low caloric intake (320 
calories for women and 380 calories for men provided by a commercial meal replacement shake) 
and 12 hours of feeding ad libitum. Results revealed a significant body weight loss (p≤0.05) of 8.5 ± 
1.7 kg (8.0 ± 1.4%) after 8 weeks of study.  
An intervention with the same duration as the above study, which achieved similar results 
despite having a different IF protocol, was developed by Eshghinia and Mohammadzadeh (2013). In 
this study 15 obese participants, aged between 20 and 45 years, took part in an eight weeks study 
divided into two phases: two weeks of control period and 6 weeks of ADF during which participants 
should consume 25 to 30% of energy needs on three fasting days, eat a 1700-1800 kcal/d diet during 
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another 3 days of the week and eat ad libitum on the seventh day a week. After the six weeks of 
intervention, body weight significantly decreased (p<0.001) by 6 ± 1.2 kg, which represented a mean 
body weight loss of 7.1%. Additionally, a significant reduction (p<0.001) in fat mass (45.82 ± 4.16 kg 
to 42.98 ±4.01 kg) and in waist circumference (87.87 ± 9.74 to 82.86 ± 9.68 cm) was reported. 
However, this study presented some limitations, such as, the absence of a control group to compare 
the results with, a small sample size and a short intervention period. 
A similar decrease in  body weight was experienced in the study by  Varady et al. (2009) after 
12 weeks of ADF regime implemented in three phases: two weeks of pre-loss control; four weeks of 
alternate day fasting with controlled food intake (provision of a meal on fasting days that 
represented 25% of baseline energy needs) and four weeks of alternate day fasting with self-
selected food intake (no food provided but participants could still consume 25% of their baseline 
needs). Results shown that during the alternate day fasting phases, participants lost a mean of 5.6 ± 
1.0 kg  (5.8 ± 1.1%) from baseline (p<0.01) (0.67 ± 0.1 kg/week during  ADF controlled food intake 
phase and 0.68 ± 0.1 kg/week during ADF self-selected food intake phase). A significant decrease 
(p<0.01) in body fat mass of 5.4 kg (from 45.0 ± 1.6% to 42.1 ± 2.0%) was also experienced by 
participants.  
A study by Eshghinia and Gapparov (2011) tested 26 obese females during a four week study 
of controlled food intake during ADF diet. Participants consumed a very low caloric diet (VLCD) (25 
to 40% of their energy needs) for three days a week and underwent a moderate caloric restriction 
diet in the remaining four days. After four weeks of study, participants significantly decreased 
(p<0.0001) body weight by 4.7% (from 96.87 ± 21.34 to 92.16 ± 19.85 kg).  
Recently, Klempel, Kroeger and Varady  (2013) recruited 32 obese females aged between 25 
and 65 years and randomized them either to a ADF high fat (ADF-HF) diet (45% fat) or to a ADF low 
fat (ADF-LF) diet (25% fat) during ten weeks, divided into two phases: two weeks of a weight 
maintenance period followed by eight weeks of ADF intervention, during which they consumed 25% 
of their energy needs on the fasting day and 125% of their energy needs on the feed day, either on a 
high fat or low fat diet. During the 2 weeks of weight loss control, both groups significantly lost body 
weight (p<0.001) despite no caloric restrictions prescribed.  During the intervention period, body 
weight and fat mass significantly decreased from baseline values (p<0.0001) by 4.8 ± 1.1%  and 5.4 ± 
1.5 kg in ADF-HF group and by 4.2 ± 0.8% (4.3 ± 1.0kg) and 4.2 ± 0.6 % (3.7 ± 0.7kg) in the ADF-LF 
diet, respectively. No significant differences between groups for body weight loss and fat mass were 
reported at any point, which indicates that an ADF-HF diet is equally as effective as an ADF-LF.  
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Another recent study from Bhutani, Klempel, Kroeger, Trepanowski and Varady (2013) 
combined an ADF diet with exercise to report which intervention induces superior changes in body 
composition compared to each intervention alone. With this purpose, they studied 64 obese 
participants for 12 weeks that were randomly allocated in one of the following groups: combination 
of ADF plus endurance exercise; only ADF; only exercise; or control group. After 12 weeks of study, a 
significant decrease in body weight (p<0.05) in the combination, ADF and exercise groups (6 ± 4 kg, 3 
± 1 kg, and 1 ± 0 kg, respectively) were reported. Also, significant reductions were described in fat 
mass and waist circumference in the combination group. Evidence from this paper suggests that ADF 
approaches in combination with endurance exercise produces superior changes in body weight and 
body composition when compared to individual treatments.  
Despite all these studies proving the effectiveness of IF approaches, a crossover design study 
developed by Soeters et al. (2009) found no significant changes in body weight and in body fat from 
baseline values after two weeks of  20 hours of fasting every second day.  
No significant changes (p>0.05) in body composition were also reported in a randomized 
crossover study conducted by Stote et al. (2007) with the purpose to compare meal frequency. 
Participants followed either a protocol of 3 meals/day (breakfast, lunch and dinner) or 1 meal/day 
consumed within a four hour period (which means that they were fasting for 20 hours every day), 
during 8 weeks.  Despite no significant differences reported, the consumption of 1 meal/day reduced 
body weight and body fat mass by 1.4 kg and 2.1 kg, respectively, while no changes were observed 
after the 3 meals/day diet. According to the authors, the changes in body composition observed 
after the 1 meal/day diet may be due to a deficit of 65 kcal in daily energy intake and/or to the effect 
that eating patterns could have on metabolic activity.  
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Lean tissue 
 It is documented that short-term fasting increases proteolysis (Fryburg, Barrett, Louard, & 
Gelfand, 1990; Tsalikian, Howard, Gerich, & Haymond, 1984), and therefore it is expected to observe 
losses in lean tissue due to IF regimes. However, one of the postulated advantages of IF approaches 
is that it helps to spare lean tissue (Varady, 2011). 
In the study of Heilbronn, Smith, Martin, Anton and Ravussin (2005), a significant loss 
(p≤0.05) of 0.6 kg from fat free mass (p < 0.001) was observed after 22 days of alternate day fasting 
(ADF). Similar results were reported by Halberg et al. (2005), when after two weeks in a regime of IF, 
participants lost body weight but increased body fat, which means that the body weight lost was 
from lean tissue.  
On the other hand, in the study of Varady et al. (2009) no significant changes were 
experienced by participants in lean tissue from baseline to the end of the study (-0.1 ± 0.1 kg). 
Furthermore, no significant changes in lean tissue were described in the study of Stote et al.(2007) 
after the consumption of 1 meal/day or 3 meals/day. 
In the study from Soeters et al. (2009), despite a slight increase in lean tissue, no significant 
differences were described after fasting every second day for 20 hours during two weeks. However, 
the authors stated that the duration of the study might have been insufficient to observe 
measurable effects on muscle mass. 
In another study from Klempel et al. (2013), no significant changes in lean tissue from 
baseline values were experienced by the participants after a regime of ADF high fat or ADF low fat 
diet. Despite this, an increase in lean tissue of 1.2 ± 1.3 kg and 0.5 ± 0.7 kg in the ADF-HF or ADF-LF 
groups, respectively, was observed. 
In conclusion, from the limited literature available in humans, it appears that during IF 
schemes, losses in lean tissue are minimal or none and, therefore, there is evidence to claim the 
spare in lean tissue as one of the major advantages of IF regimes. 
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Intermittent Fasting and resting energy expenditure 
 During fasting periods, due to the low levels of insulin in the bloodstream, the secretion of 
epinephrine is stimulated, which in turn was reported to stimulate metabolic rate (Staten, 
Matthews, Cryer, & Bier, 1987). Beyond the existing lack of literature regarding the effects of IF 
approaches on REE due to the novelty of the topic, the available research is also discordant and 
inconclusive. Among this issue, Heilbronn et al. (2005) reported no significant differences in resting 
metabolic rate (RMR) from participants between baseline (6675 ± 283 kJ/d) and day 22 (6329 ± 260 
kJ/d), while Soeters et al. (2009) reported a significantly lower (p≤0.05) REE after two weeks of IF in 
comparison with a standard diet (SD). In accordance with the authors, the reduction in REE would 
result in a difference of 21 535 kcal per year, approximating the equivalent of 3 kg of body fat, which 
suggests that IF can lead to body weight gain if energy intake were not adjusted.  
On the other hand and despite not being a study about intermittent fasting, Zauner et al. 
(2000) tested the effects of short term starvation on metabolic rate during 84 hours of fasting 
(measurements were made after the first overnight fast, after 36 hours, 60 hours and 80 hours). 
Results showed that REE increased from day 1 to day 2 and from day 2 to day 3 and slightly 
decreased at day 4 (3.97 ± 0.9 kJ/min;  4.37±0.9 kJ/min; 4.53 ± 0.9 kJ/min; 4.43 ± 0.9 kJ/min, 
respectively). The authors’ hypothesized that the increase in metabolic rate could be due to a 
progressive increase in norepinephrine concentration.  
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Intermittent Fasting and Energy Intake 
 Anson et al. (2003) described that mice placed in IF regimes ate almost twice as much as 
mice fed ad libitum, which means that the mice subjected to IF diets were compensating for the 
fasting periods by increasing their food intake. Once that IF regimes are characterized by  fasting 
periods followed by an ad libitum feeding window, it is hypothesized that participants will 
compensate during feeding periods for the shortage in energy intake promoted by the fasting 
period, as it was reported in mice. 
 Regarding this issue, a human trial conducted by Johnstone et al. (2002) submitted 24 
normal weight (BMI 20–25 kg/m2) participants (12 men and 12 women) to a 2-day control period 
(maintenance) and a separate 2-day test period (fast). During the day one of control period, 
participants were fed 1.6 x times their RMR and during day two, were given ad libitum access to 
food. During the test period, participants consumed a maintenance diet (1.6 x RMR) and then 
underwent a 36 hour fasting period. During day two, ad libitum access to food was given. Results 
from this short intervention revealed that participants consumed 10.2 vs 12.2 MJ/day (p = 0.049) 
during the post-maintenance and post-fast periods, respectively. On the post-fast period, energy 
intake was 20% greater than control values, while ad libitum intake in control treatment  was 
approximately the required energy to maintain participant’s body weight (1.6 x RMR). The intake of 
fat was significantly higher in the post-fast period (5.1 MJ/day) than in the post-maintenance period 
(3.7 MJ/day) while no significant differences were reported in carbohydrate and fat intake. Despite 
these results, participants consumed much less energy than required to compensate for the energy 
reduction induced by the fast. 
On the other hand, Södersten, Bergh  and Zandian (2006) reported that after a period of 
fasting (skipping dinner on the day before and breakfast on the day of testing), women ate about 
20% less while men ate about 30% more after food deprivation, in relation to the absence of a 
fasting period before the testing meal. However, this was a single fasting period experience and 
therefore, no further conclusions can be extrapolated from it.  
 Klempel, Bhutani, Fitzgibbon, Freels and Varady (2010) reported that average energy intake 
on the fast days (501 ± 28 kcal) and  on feed days (1801 ± 226 kcal) (26 ± 3 % of baseline needs  and 
95 ± 6% of baseline energy needs, respectively ) was similar to the average energy intake during the 
control phase (1937 ± 180 kcal). These results reveal that participants did not increase their energy 
intake on the feed day as a way of compensating for the energy restriction on the fast day, as 
hypothesized by the authors. This paper suggests that participants are able to consistently limit their 
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energy intake to 25% of their energy needs on fast days and not over intake on feed days. However, 
the authors recognized that there is a gap between the caloric restriction calculated by the food 
records (37% energy restriction every day) and the body weight lost by the participants. If this was 
the actual percentage of caloric restriction, participants would have lost 1.2 kg/week instead of the 
0.7 kg/week as reported, which suggests underreporting of energy intake (Klempel, et al., 2010).  
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Reference Participants Trial length IF Protocol Findings 
 
Heilbronn et al. (2005) 
 
n=16 
8 women and 8 men 
Healthy non-obese 
BMI 20.0 – 30.0 
Age 23 – 53 y 
 
 
 
3 weeks 
 
Fast day: 24-h fast 
Feast day: ad libitum feeding 
(food not provided) 
 
2.5 ± 0.5% body weight* 
4 ±1% body fat (0.8 kg)* 
0.6 kg fat free mass * 
= RMR 
Halberg et al. (2005) n= 8 
 
Men 
 
Age 25±0.1 yr 
 
BMI 25.7±0.4 kg/m2 
 
 
2 week 
 
The aim was not to observe changes in 
weight and/or body composition 
Fast day: 20-h fast 
(2200–1800) 
 
Feed day: ad libitum feeding 
 
Participants were instructed to eat enough food to 
maintain body weight 
 
 
 
 
0.9 kg body weight 
0.3% body fat 
 
Johnson et al. (2007) 
 
n= 9 
7 women and 2 men 
Sedentary 
BMI >30, asthma 
8 weeks 
The aim of this study was not to decrease 
weight or change body composition 
Fast day: 36-h very low caloric diet (320 kcal to women, 
380 to men) 
Feed day: 12-h ad libitum feeding 
(food not provided) 
 
8% body weight* 
 
   
 
 
Table 1: Summary of the effects of intermittent fasting on body weight and body composition on human studies. *Significant differences from baseline values; BMI - body mass index; IF - 
Intermittent fasting; RMR- resting metabolic rate; SD - standard diet; ADF - alternate day fasting; ADF-HF - alternate day fasting high fat diet; ADF-LF - alternate day fasting low fat diet; 
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Stote et al. (2007) 
 
n= 15 
10 women and 5 men 
Age 40–50 y 
18 ≥BMI≤25 
 
Randomized crossover design 
2 x 8 weeks 
 
11 weeks washout period between 
treatments 
Control:  3 meals/d (breakfast, lunch and dinner) 
 
Experimental:  1 meal/d 
20-h of fast everyday (2100-1700) 
 
(calories for body weight maintenance; same 
macronutrients distribution; 
all food provided) 
 
 
 
 
EXPERIMENTAL: 
1.4 kg body weight 
2.1 kg body fat mass 
 
CONTROL: 
no reported changes 
Varady et al. (2009) 
 
n=16 
30 ≥BMI≤39.9 
Age 35 – 65 y 
10 weeks 
 
Phase 1: 2 weeks preloss control 
Phase 2: 4 weeks ADF controlled food 
intake 
Phase 3: 4 weeks ADF self-selected food 
intake 
 
 
 
Fast day: 24-h very low caloric diet (≤25% of energy needs) 
Feed day: <30% fat 
(food provided on fast day during ADF controlled food 
intake) 
5.8 ± 1.1% body weight* 
5.4 kg fat mass* 
0.1 ± 0.1 kg Lean tissue 
 
Soeters et al. (2009) n = 8 
20 ≥BMI≤25 
 
Age 18 – 35 y 
 
2 weeks 
 
Cross over design 
 
4 weeks washout period between 
treatments 
IF: Fast day: 20-h fast (2200–1800) 
Feast day: ad libitum feeding 
 
SD: no skipping meals 
 
Caloric intake and macronutrient consumption were equal 
 
 
 
 
No significant differences in body 
weight, fat mass and lean tissue 
between IF and SD 
 
IF decreased REE* 
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Bhutani et al. (2013) n=64 
Obese 
12 weeks 
 
4 groups: 
1) Combination (ADF plus exercise) 
2) ADF 
3) Exercise 
4) Control 
 
 
 
No data about ADF protocol Body weight 
1) 7.1±1.0%, 
2) 5.8±1.0% 
3) 1.4±0.5% 
Fat mass 
1) 6.3±1.5% 
 
Eshghinia and 
Mohammadzadeh  
(2013) 
n= 15 
Obese 
Age 20–45 y 
 
 
8 weeks 
 
Phase 1: 2 weeks of control period 
 
Phase 2: 6 weeks of ADF 
Control period: maintain body weight 
 
ADF phase: Fast day: 3 non consecutive days (25 to 30% 
energy needs) 
Feed day: 3 non consecutive days of 1700-1800 kcal/d diet 
and 1 days of ad libitum per week. 
 
7.1% of weight loss* 
Fat mass* 
Waist circunference* 
 
Eshghinia and 
Gapparov (2011) 
n = 26 
Obese females 
 
 
4 weeks ADF diet: 
VLCD during 3 days/week (25 to 40% energy needs) 
Caloric restriction during 4 days/week 
4.7% body weight 
Waist circunference 
 
Klempel et al. (2013) n = 32 
Obese females 
Age 25 – 65 y 
10 weeks 
 
Phase 1: 2 weeks weight maintenance 
 
Phase 2: 8 weeks ADF either in a high fat 
diet (45% fat) or low fat diet (25%) 
Control period: maintain body weight 
 
ADF phase: 
Fast day: 25% of energy needs 
Feed day: 125% of energy needs on a high or low fat diet 
ADF-HF: 
4.8 ± 1.1% body weight* 
5.4 ± 1.5 kg fat mass* 
 
ADF-LF: 
4.2 ± 0.8% body weight* 
4.2 ± 0.6 kg fat mass* 
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Conclusion 
 
 A summary of the effects of IF intervention on body weight, body composition and REE in 
human trials was presented in this review paper. The use of IF approaches as a method to decrease 
body weight and change body composition is an emergent topic and therefore, there is a limited and 
a lack of research on the theme. However, the existent evidence in humans suggests that IF 
approaches are an effective method to decrease body weight and body mass with no change, or 
minimal changes in lean tissue. During IF regimes, alterations in body composition can be observed 
even in short term interventions (3-8 weeks), during which reductions in body weight of 3-8% from 
baseline can be experienced.  
 In respect to REE, the evidence to date is inconsistent, therefore more trials are necessary in 
order to clarify the actual effects of IF interventions on metabolic rate. Also, more research is 
needed to elucidate the consequences of fasting periods on energy intake during the feeding 
window.  
 The popularity of IF regimes is exponentially increasing, therefore, it appears essential for 
the development of research in this area, especially regarding the effectiveness of IF schemes in 
people with normal weight, since most of the literature on this subject was conducted in overweight 
and/or obese individuals. 
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Research Article 
 
 
Journal of choice to submit publication 
It is with intention to submit the following scientific article to the Nutrition & 
Metabolism journal. As it is described by the journal’s aims and scope, the publication content 
focuses on integration of nutrition and clinical investigation, with special interest on obesity 
studies as well as biochemistry of metabolism. In this sense, this article involves the 
comprehension of the effects of food deprivation on body composition and resting energy 
expenditure as a result of metabolic changes due to it. 
The evidence provided by this article is original and innovative and it would contribute 
to a further understanding on the topic and to extend the current limited literature regarding 
it. 
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Intermittent Fasting – How long is enough? 
 
Abstract 
Introduction: Intermittent fasting (IF) has become a popular method to decrease body weight 
and body fat mass, however, no one to date has studied the optimal time frame of 
fasting/feeding and the impact it has on total body weight, body composition, resting energy 
expenditure and the feeding patterns in response to the reduction of energy intake due to 
these fasting periods.  
Methodology: Participants were divided into four different groups: Control group (8 hours of 
fasting/16 hours of feeding every day), 16-h (16 hours of fasting/8 hours of feeding in alternate 
days (AD), 20-h (20 hours of fasting/4 hours of feeding in AD), and 24-h (24 hours of fasting in 
AD). The intervention was designed to last for 9 weeks and was divided into two phases: first 
phase- 1 week of control; second phase– 8 weeks of intervention.  
Results:  A decrease in body weight and in body fat mass were observed in the 16-h (0.6 ± 1.2 
% and 0.64 ± 0.50 kg, respectively), in the 20-h (5 ± 2% and 3.53 ± 2.94 kg, respectively) and in 
the 24-h group (3.1 ± 4.6% and 2.70± 4.88 kg, respectively). Regarding REE, no significant 
differences were observed at the end of the study in relation to baseline values.  
Conclusions: Findings from this paper suggest that IF regimes characterized by fasting lengths 
of 20 hours appear to be more effective to achieve reductions in body weight and in body fat 
mass, while sparing lean tissue. 
Keywords: Intermittent fasting, body composition, resting energy expenditure, energy intake. 
 
 
  
34 
 
Introduction 
 Intermittent Fasting (IF) approaches have been studied and proposed as a way to 
mimic the cycles of high and low energy consumption, characteristic of the Paleolithic era 
(Halberg, et al., 2005; Neel, 1962), to which our genetic profile are programmed. (Chakravarthy 
& Booth, 2004; Mattson, 2005; Zimmet & Thomas, 2003). Furthermore, for the last ten years, 
IF regimes have become popular as a successful method to lose body weight and fat mass, 
while sparing lean tissue (Bhutani, et al., 2013; Eshghinia & Gapparov, 2011; Eshghinia & 
Mohammadzadeh, 2013; Klempel, et al., 2013; Varady, et al., 2009). However, one of the 
concerns with the use of IF as a solution to body weight loss is the energetic overconsumption 
during feeding periods as observed in mice models (Anson, et al., 2003) that can lead to an 
unsuccessful body weight loss or even to a body weight gain, depending on the rate of energy 
compensation.  
 Despite the recent popularity of IF approaches,  no one to date has studied the optimal 
time frame of fasting/feeding and its impact on total body mass, fat mass, lean tissue and 
resting energy expenditure. Therefore, there is a need to identify the ideal time period of 
fasting in order to achieve optimal intervention periods for such protocols.  
 Thus, the aim of this project is to study the impact that different lengths of 
fasting/feeding have on: 1) body weight; 2) body composition; 3) resting energy expenditure 
and 4) eating patterns during the feeding period.  
 The objective of this study is to do an 8 week intervention that examines the changes 
in body weight, body composition and in resting energy expenditure between the baseline, 
week four, and week eight. Furthermore, a nutritional food analysis will be conducted in order 
to determine if participants ingest greater energy amounts during the feeding period, as a way 
of compensating for the reduction of energy intake over the fast period. 
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Methodology 
Ethical approval 
  The study was approved by the ethical committee of the University of Chester and 
participants gave their written informed consent. 
 
Recruitment and inclusion and exclusion criteria 
 University students and staff were invited to take part in the study via email, and 
Chester residents were recruited through flyer distribution in local gyms. Exclusion criteria to 
select participants were: being pregnant or having been pregnant less than 6 months before 
the commencement of the study, pacemaker users, having diabetes, being on a diet for weight 
loss, history of cardiovascular disease and taking lipid or glucose lowering medications. 
  
Study design 
 This was a controlled interventional study with a matched group design. Participants 
were allocated to four different groups by Body Mass Index (BMI) matching criteria, as follows:  
Table 2: Fasting length and feeding window per group 
Groups Fasting Feeding Frequency of fasting 
Control 8 hours (overnight) 16 hours Everyday 
16-h 16 hours 8 hours Alternate days 
20-h 20 hours 4 hours Alternate days 
24-h 24 hours 0 Alternate days 
 
 A control group was added to the study in order to compare the remaining groups 
against a normal eight hour overnight fast. The study was designed for nine weeks, from which 
the first was a control week, where data about eating patterns were collected through a 7 day 
food diary, with the following weeks serving as an intervention. During the remaining eight 
weeks of study, participants had to fast the length of which depended on the group they were 
allocated.  
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 Participants received the participant information sheet (Appendix 1), informed consent 
(Appendix 2), food diary (Appendix 3) and food portion photographs (Appendix 4) by email. As 
soon as they started filling in the food diary, the control week began. At the end of the control 
week, participants attended an exercise physiology research laboratory at the University of 
Chester and brought with them signed informed consent forms and food diaries. Participants 
were instructed to fast overnight, to abstain from alcohol and caffeine intake for 24 hours and 
not to conduct any exercise for 48 hours prior to the visit. During the lab session, stature, total 
body mass, body composition and resting energy expenditure (REE) were measured. The same 
procedures were repeated again at the end of week 4 and week 8, as demonstrated in Figure 
11. 
 
 Figure 11: Study Design. FD - Food Diary; BC – Body Composition 
 
 After the completion of baseline testing, participants started the fasting periods in 
accordance to the group where they were allocated. Participants were free to decide at what 
time they wanted to start fasting but they were told to keep the same starting time during the 
8 weeks. An example of a 16 hour fasting scheme is shown in Table 3. 
 
Table 3: Example of a 16 hour fasting scheme starting at 3 pm in alternate days 
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Week 
1 
 … to 7 am  … to 7 am  … to 7 am  
From 3 pm…  From 3 pm…  From 3 pm…  From 3 pm… 
Week 
2 
… to 7 am  … to 7 am  … to 7 am  … to 7 am 
 From 3 pm…  From 3 pm…  From 3 pm…  
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 During feeding periods, participants were told to comply with their normal eating 
habits and on fasting periods, they were allowed to consume up to 25% of their daily energy 
requirements (DER) (with exception of the control group, who were instructed to not consume 
food or drinks – only water, coffee and tea without sugar -  during their overnight fast).  
 To calculate DER, REE values were multiplied by the appropriate physical activity level 
(PAL) (Black, Coward, Cole, & Prentice, 1996), which was reported by the participants during 
baseline and fourth week assessment. Also, participants received a list of food items with the 
respective amount of calories supplied by a portions or serving guide (Appendix 5) with the 
aim of helping them control energy intake during fasting periods . 
 
Stature and body weight 
 Stature was measured using a wall-mounted Harpenden stadiometer (Holtain, 
Crymych, Dyfed, UK) with participants in bare feet and the head positioned in the ‘Frankfurt 
plane’. Total body mass  was measured using the electronic Tanita®-scale attached to the 
BodPod® S/T (Life Measurement Inc., California, USA), with participants wearing  swimming 
wear or tight sports clothes. 
 
Body composition 
 Body composition was assessed with an Air Displacement Plethysmograph (ADP) 
device, commercially known as the BodPod® S/T (Life Measurement Inc., California, USA), 
which uses whole body densitometry to determine body composition. Studies regarding 
validity and reliability of this method have demonstrated a good agreement with that derived 
from hydrostatic weighing (Biaggi, et al., 1999; Fields, Goran, & McCrory, 2002; Levenhagen, et 
al., 1999; McCrory, Gomez, Bernauer, & Mole, 1995; Nuñez, et al., 1999), which is considered 
the gold standard of the densitometric methods (Collins & McCarthy, 2003).   
Participants were assessed with swimming wear or tight sports clothes, with a swim cap to 
provide optimal compression of the scalp, and without jewelry and accessories. 
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Resting Energy Expenditure 
 REE was evaluated by indirect calorimetry based on respiratory exchange 
measurement using Oxycon Pro (Viasys Healthcare, Hoechberg, Germany). The device 
measures oxygen consumption and carbon dioxide production, and therefore it is possible to 
calculate the total amount of energy produced (Battley, 1995).  Oxycon Pro has been shown to 
be a valid system to measure oxygen consumption and carbon dioxide production, achieving 
similar results as those obtained with a Douglas bags, the gold standard for the collection and 
analysis of respiratory gases (Carter & Jeukendrup, 2002).  
 Device calibration was done before performing each measurement, while participants 
were resting.  A face mask was placed on participants and they were instructed to breathe 
normally, to lie down on their back and to maintain the same position for 30 minutes, during 
which time the test ran. Participants were instructed to relax but not to fall asleep during the 
measurement. REE data were recorded every minute but the first 25 minutes measured were 
discarded to reduce errors associated with excitement, restlessness and nervousness. 
 
Energy Intake 
 Energy intake was assessed through food diaries as literature suggests this method is a 
reliable technique that produces valid results, despite its tendency to underestimate real 
intakes (De Castro, 1994; Mertz, et al., 1991). 
 Each participant completed a 7-day food diary on 3 different occasions, during the 
baseline week and during week 4 and week 8 of the study. Therefore, a total of 21 days of food 
records were collected for each participant during the 3 different lab assessments. Participants 
were instructed to record every consumed item (drinks included) with as much detail as 
possible in the food diary provided, and to include information about the time of the meal and 
the food preparation.  Regarding portion size, participants were told to weigh the food if 
possible, otherwise, to estimate food quantities with the use of household measures (cups and 
spoons) or to describe portion sizes as small, medium or large with the aid of food portion 
photographs provided. Participants were also instructed to attach food labels to the food diary 
every time a ready-made meal was consumed. 
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 For the analyses of food diaries, all food items were entered into the nutritional 
software Food Processor SQL®, version 9.7.0. (ESHA Research, USA) by the same individual to 
diminish inter-investigator bias. Food Processor SQL calculates nutritional intake based on food 
composition tables from the United States Department of Agriculture. Food items that were 
not available in the software’s database were added using the food labels of the foods 
themselves or through information provided by McCance, Widdowson, Food Standards and 
Institute of Food (2002). The use of the United States of America food composition table to 
analyse British food diaries can introduce errors associated with different nutritional 
composition of foods, particularly fruits and vegetables, and due to different manufacturing 
processes when it comes to processed foods. Despite this, Food Processor, as determined by 
McCullough et al. (1999), offers a valid analysis for energy, fat, carbohydrate, protein, 
cholesterol, calcium, potassium, magnesium, iron and sodium,  as the absolute deviations are 
less than 15%, with the exception of iron, in relation to a chemical analysis. 
 
 
Statistical Analysis 
 For statistical analysis, the computer software IBM SPSS version 21 was used. Data 
were expressed as means ± SD. Tests for normality were included, and if the sample did not 
violate this assumption, a One-way Independent ANOVA test was performed to identify 
significant differences between groups and a One-way repeated measures ANOVA test was 
applied to determine significant differences between baseline, week four and week eight 
measures (followed by multi paired t-tests). If the sample violated the normality assumptions,  
a Kruskal Wallis test was conducted to determine significant differences between groups 
(followed by Mann-Whitney U test) and a Friedman test was applied to determine significant 
differences between baseline, week four and week eight (followed by Wilcoxon tests).  
 A significance level was set at p≤0.05 and effect-size was calculated by Cohen’s d 
through the use of an online calculator (Becker, 1999). 
Results 
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Participant’s dropout and baseline characteristics 
 For this study 27 subjects had volunteered. From these, 7 were excluded for not 
meeting the criteria, 2 dropped out before the beginning of the study (one from the 20-h 
group and another one from the 24-h group) and 1 dropped out after the fourth week of the 
study (from the 24-h group). Therefore, 18 people (women=11; men=7) started the study but 
only 17 completed the 8 weeks of intervention (women=10; men=7).  
 Baseline characteristics of the participants who completed the study are shown in 
Table 4. Table 4 also displays data regarding stature and body weight which were used to 
calculate Body Mass Index (BMI), which was used as matching criteria to allocate participants 
into groups. A table with the allocated groups by matching BMI criteria is presented in  
Appendix 6. 
 
Table 4: Participant's reported values regarding stature and body weight and characteristics at baseline from 
participants who finished the study by group. 
 
Reported 
Values 
(n=17) 
Mean ± SD 
 
Baseline Values 
(n=17) 
Mean ± SD 
Control 
(n=5) 
16-h 
(n=5) 
20-h 
(n=4) 
24-h 
(n=3) 
Age (years) - 36.8 ± 9.8 33.4 ± 33.1 33.3 ± 15.2 41.0 ± 5.5 
Stature (cm) 169.5 ± 8.7 168.4 ± 9.7 168.9 ± 6.7 174.0 ± 8.1 170.1 ± 13.3 
Body Weight (kg) 71.5 ± 14.8 67.3 ± 10.4 71.2 ± 18.1 71.7 ± 12.0 76.3 ± 23.3 
BMI (kg/m2) 24.7 ± 3.3 23.7 ± 3.9 24.8 ± 4.6 23.6 ± 2.6 25.8 ± 3.9 
Body Fat (kg) - 17.6 ± 9.8 18.3 ± 5.7 19.8 ± 6.0 23.5 ± 9.7 
Lean Tissue (kg) - 49.7 ± 9.1 52.9 ± 15.8 51.9 ± 6.5 52.7 ± 15.2 
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Body Weight 
 Table 5 describes the mean body weight at baseline, week 4 and week 8 in each group. 
No significant differences regarding body weight were described between groups at baseline.   
After 4 weeks of study, the 16-h, 20-h and 24-h groups experienced a decrease in body weight 
(-0.22± 0.67 kg, p=0.505; -2.48± 1.94 kg, p=0.84; and -2.0 ± 3.50 kg, p=0.433, respectively), 
while the control group experienced an average increase (p=0.278) of 0.94± 1.67 kg (Figure 
12).  
 Between week 4 and week 8 assessment, a significant change (p=0.000) in body 
weight (-1.2 ± 0.13 kg) in the 20-h group was observed (Figure 12). At the end of the study, the 
average body weight change was not significant in the control, 16-h and 24-h groups (0.62 ± 
1.2 kg, p=0.314; - 0.24 ± 0.86, p=0.566; - 2.97 ±4.70, p=0.389, respectively) but was 
significantly different (p=0.29) in the 20-h group (-3.65 ± 1.86 kg) (Figure 12).  After 8 weeks of 
intervention, significant differences (p=0.039) between groups regarding body weight change 
were observed, namely between the control and the 20-h group (p=0.004) and between the 
16-h and 20-h group (p=0.008) (Figure 13).  
 The magnitude of the effect of fasting on body weight was small in the control (d=-
0.06), 16-h (d=0.01) and 24-h (d=0.14) groups, but was considered a medium effect on the 20-
h group (d=0.32). 
 
Table 5: Body weight mean values at baseline, week 4 and week 8. P value represents the differences from baseline 
to week 4 and week 8. Effect size was calculated by difference from baseline to week 8. B – baseline; Wk4 – week 4; 
Wk8 – week 8.  
 Baseline Week 4 Week 8 
 Mean ± SD 
(kg) 
Mean ± SD 
(kg) 
p value 
(Wk4 - B) 
Mean ± SD 
(kg) 
p value 
(Wk8 - B) 
d 
(Wk8 - B) 
Control (n=5) 67.3 ± 10.4 68.2 ± 11.5 0.278 67.9 ± 11.2 0.314 -0.06 
16-h (n=5) 71.2 ± 18.1 71.0 ± 18.7 0.505 71.0 ± 18.9 0.566 0.01 
20-h (n=4) 71.7 ± 12.0 69.3 ± 10.5 0.084 68.1 ± 10.5 0.029 0.32 
24-h (n=3) 76.3 ± 23.3 74.3 ± 20.1 0.433 73.3 ± 19.2 0.389 0.14 
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Figure 12: Body weight (and the corresponding values of body fat mass and lean tissue values) at baseline, week 4 and week 
8. * Significant difference from baseline, p≤0.05; # Significant difference from week 4, p ≤0.05. B – baseline; Wk4 – week 4; 
Wk8 – week 8.  
 
43 
 
Body Fat  
 Data regarding body fat mass at baseline, week 4 and week 8 is available in Table 6. No 
significant differences were observed on body fat mass between groups at baseline 
assessment (p= 0.758).   
 At week 4, body fat mass decreased in the 16-h, 20-h and 24-h groups (0.74 ± 1.44 kg, 
p=0.316; 1.8± 1.86 kg, p=0.148; and 1.8± 3.64 kg, p=0.482: respectively) and increased 
(p=0.505) by 0.28 ± 0.86 kg in the control group (Figure 13).  No significant changes were 
observed on body fat from week 4 to week 8.  
 After 8 weeks, a significant decrease (p=0.047) in body fat mass was experienced by 
the 16-h group (from 18.3 ± 5.7 kg to 17.6 ± 6.1 kg; -0.64 ± 0.50 kg). In the remaining groups, 
namely the control, 20-h and 24-h group, body fat change was the following: 0.34 ± 1.6 kg, 
p=0.656; - 3.53 ± 2.94 kg, p= 0.096; and -2.70± 4.88 kg, p=0.439 respectively. No significant 
differences (p=0.889) in body fat were seen between groups at the end of the study. 
 Regarding Cohen’s effect size, d value suggested a small practical significance in the 
control (d=-0.04) and 16-h group (d= 0.12), while a medium magnitude was observed in the 
20-h (d=0.71) and 24-h group (d=0.30). 
 
Table 6: Body fat mass mean values at baseline, week 4 and week 8.  P value represents the difference from 
baseline to week 4 and week 8. Effect size was calculated by difference from baseline to week 8. B – baseline; Wk4 – 
week 4; Wk8 – week 8. 
 Baseline Week 4 Week 8 
 Mean ± SD 
(kg) 
Mean ± SD 
(kg) 
p value 
(Wk4 - B) 
Mean ± SD 
(kg) 
p value 
(Wk8 - B) 
d 
(Wk8 - B) 
Control (n=5) 17.6 ± 9.8 17.9 ± 9.8 0.498 18.0 ± 10.5 0.715 - 0.04 
16-h (n=5) 18.3 ± 5.7 17.5 ± 5.4 0.345 17.6 ± 6.1 0.047 0.12 
20-h (n=4) 19.8 ± 6.0 18.0 ± 4.3 0.148 16.3 ± 3.5 0.096 0.71 
24-h (n=3) 23.5 ± 9.7 21.7 ± 7.8 0.482 20.8 ± 8.2 0.439 0.30 
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Figure 13: Changes in body weight, body fat mass and lean tissue at week 4 and week 8 by fasting group. * Significant difference from 
baseline, p≤0.05; # Significant difference from week 4, p ≤0.05; ¥ Significant difference from control and 16-h group, p ≤0.05. Wk4 – week 
4; Wk8 – week 8. 
45 
 
Lean Tissue  
 Lean tissue values at baseline, week 4 and week 8 are shown in Table 7. At baseline, no 
significant differences in lean tissue were observed between groups. 
After 4 weeks of intervention, the control and 16-h group saw an increase of 0.66 ± 1.4 kg 
(p=0.361), and 0.52 ± 2.04 kg (p=0.680), respectively. On the other hand, the 20-h group 
experienced a significant decrease (p=0.003) of 0.68 ± 0.15 kg and the 24-h group a reduction 
(p=0.199) of 0.17± 0.15 kg (Figure 13). During the last 4 weeks of study, no significant changes 
in lean tissue were experienced by any of the groups. 
 At the end of the study, no significant changes in lean tissue were experienced 
between groups (p=0.978). From baseline to week 8, lean tissue increased by 0.28 ± 1.4 kg in 
the control (p=0.680) and by 0.40 ± 0.70 kg in the 16-h group (p=0.268), and decreased by 0.13 
± 1.12 kg in the 20-h (p=0.837) and by 0.27 ± 0.38 kg in the 24-h (p=0.347) (Figure 13). A low d 
value was observed in all the groups which means that fasting had a low effect on changing 
lean tissue (control: d=-0.02; 16-h: d=-0.02; 20-h: d=0.01; 24-h: d=0.01). 
 
Table 7: Lean tissue mean values at baseline, week 4 and week 8. P value represents the differences from baseline 
to week 4 and week 8. Effect size represents the difference from baseline to week 8. B – baseline; Wk4 – week 4; 
Wk8 – week 8.  
 Baseline Week 4 Week 8 
 Mean ±SD 
(kg) 
Mean ±SD 
(kg) 
p value 
(Wk4 - B) 
Mean ±SD 
(kg) 
p value 
(Wk8 - B) 
d 
(Wk8 - B) 
Control (n=5) 49.7 ± 9.1 50.3 ± 9.5 0.361 49.9 ± 9.4 0.680 -0.02 
16-h (n=5) 52.9 ± 15.8 53.5 ± 17.7 0.680 53.3 ± 16.4 0.268 -0.02 
20-h (n=4) 51.9 ± 6.5 51.2 ± 6.5 0.003 51.8 ± 7.5 0.837 0.01 
24-h (n=3) 52.7 ± 15.2 52.6 ± 15.4 0.199 52.5 ± 15.3 0.347 0.01 
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Resting Energy Expenditure 
 Data concerning REE at baseline, week 4 and week 8 is presented in Table 8. No 
significant differences were observed between groups at any time. In appendix 7 is shown data 
about REE in kilojoules. 
 After 4 weeks, an increase in REE was observed in the control, 16-h and 24-h groups 
(79 ± 293 kcal, p=0.579; 118 ± 470 kcal, p=0.605; and 137 ± 141 kcal, p=0.233, respectively), 
while a decrease (p=0.74) of 331 ± 245 kcal was reported in the 20-h group (Figure 14).   
 At the end of the study, an increase of 164 ± 230 kcal and of 163 ± 340 kcal in the 
control (p=0.186) and the 16-h group (p=0.344), respectively, was observed. On the other 
hand, a decrease of 225 ± 258 kcal, and of 7 ± 243 kcal in the 20-h (p=0.179) and in the 24-h 
group (p=0.964), respectively, was reported (Figure 14). Despite no significant differences, a 
moderate effect size was reported regarding the effect of fasting on REE in the control (d=-
0.41), 16-h (d=-0.23) and 20-h group (d=0.53). 
Table 8: Resting energy expenditure mean values at baseline, week 4 and week 8. P value represents the 
differences from baseline to week 4 and week 8. Effect size represents the difference from baseline to week 8. B – 
baseline; Wk4 – week 4; Wk8 – week 8. 
 
 
 
 
Baseline Week 4 Week 8 
 
Mean ± SD 
(kcal) 
Mean ± SD 
(kcal) 
p value 
(Wk4 - B) 
Mean ± SD 
(kcal) 
p value 
(Wk8 - B) 
d 
(Wk8 - B) 
Control (n=5) 1631 ± 322 1710 ± 524 0.345 1795 ± 465 0.186 -0.41 
16-h (n=5) 1588 ± 759 1706 ± 958 0.605 1751 ± 625 0.344 -0.23 
20-h (n=4) 1479 ± 338 1148 ± 454 0.074 1253 ± 502 0.179 0.53 
24-h (n=3) 1515 ± 683 1652 ± 543 0.233 1508 ± 675 0.964 0.01 
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Figure 14: Changes in resting energy expenditure at week 4 and week 8 by fasting group. No significant differences 
within and between groups. REE – resting energy expenditure. 
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Energy expenditure and energy intake 
 
Energy expenditure 
Participants were provided with information concerning the energy value that they were 
allowed to consume during fasting periods, which represented 25% of DER (Table 9). Table 9 is 
presented in the appendix 8 in kilojoules. 
 
Table 9: Daily energy requirements calculated at baseline and week 4 assessment. Daily energy requirements were 
calculated by multiplying resting energy expenditure by physical activity levels. Data to the control group was not 
calculated because they were instructed to not consume food or caloric drinks during the 8 hour of overnight fast. DER - 
daily energy requirements 
  
  
Baseline Week 4 
DER 
(kcal) 
25% of DER 
(kcal) 
DER 
(kcal) 
25% of DER 
(kcal) 
Control (n=5) - - - - 
16-h (n=5) 2684 ± 935 671  ± 234 2626  ± 1484 656  ± 371 
20-h (n=4) 2224  ± 519 556  ± 130 1857  ± 660 464  ± 165 
24-h (n=3) 2403  ± 992 601  ± 248 2474  ± 894 619  ± 223  
 
 
Energy Intake 
 From the 17 participants that completed the study, 3 of them did not complete food diaries 
during week 4 and week 8, which means that only 82% of the sample gave food diaries back.  
The average of the weekly energy intake during baseline, week 4 and week 8 (including fasting and 
feeding periods) are described in Table 10, as well as the percentage of energy intake at week 4 and 
week 8 from baseline values. In the appendix 9 is shown the weekly mean of energy intake in 
kilojoules. 
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All groups, either at week 4 or week 8 were consuming less energy in relation to baseline values, 
showing a significant restriction in the 20-h group at week 4 (p=0.023)  and week 8 (p=0.047) and in 
the 24-h group at week 8 (p=0.033). The energy restrictions are derived from the fasting periods and 
for a better understanding, see Figure 15 and 16. Moreover, a large effect size was observed in the 
control (d=0.83), 20-h (d=1.38) and 24-h groups (d=1.89), while a moderate effect size was reported 
in the 16-h group (d=0.74). 
 Figure 15 and 16 show the mean energy intake during 3 complete periods of fasting and 3 
complete periods of feeding for each group at week 4 and week 8, respectively. From these figures it 
is notable that participants were able to restrict food intake during fasting periods to 25% of the 
daily energy requirements (Table 9).  
  
Table 10: Weekly mean of energy intake at baseline, week 4 and week 8. P value represents the differences from baseline 
to week 4 and week 8. Effect size represents the difference from baseline to week 8. B – baseline; Wk4 – week 4; Wk8 – 
week 8. 
 
  
  
Baseline Week 4 Week 8  
Mean  ± SD 
(kcal) 
Mean  ± SD 
(kcal) 
% 
Baseline 
p value 
(Wk4 - B) 
Mean  ± SD 
(kcal) 
% 
Baseline 
p value 
(Wk8 - B) 
d 
(Wk8 - B) 
Control (n=4) 18907 ± 3193 14016 ± 1094 74 0.064 16044 ± 3695 84 0.098 0.83 
16-h (n=3) 18596 ±5786 14753 ± 2281 79 0.200 14962 ± 3765 80 0.192 0.74 
20-h (n=4) 17219 ± 3748 11182±2238 65 0.023 12142 ± 3618 71 0.047 1.38 
24-h (n=3) 14052 ± 2701 10359 ± 2171 74 0.16 9210 ± 2424 66 0.033 1.89 
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Figure 15: Average of energy intake on fasting and feeding periods at week 4 by group 
 
 
Figure 16: Average of energy intake on fasting and feeding periods at week 8 by group 
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Discussion 
The present study evaluated the effect of different lengths of fasting on body weight, body 
composition, REE and eating patterns. From the presented data it can be concluded that IF regimes 
that include fasting lengths of 20 hours or longer are suitable for body fat loss as was previously 
demonstrated (Eshghinia & Gapparov, 2011; Eshghinia & Mohammadzadeh, 2013; Heilbronn, et al., 
2005; Klempel, Kroeger, Bhutani, Trepanowski, & Varady, 2012; Klempel, et al., 2013; Stote, et al., 
2007; Varady, et al., 2009). However, it appears that the length of fasting has influence over the 
amount of body fat mass lost, with higher reductions being experienced by the 20-h and 24-h groups 
(- 3.53 ± 2.94 kg and -2.70 ± 4.88 kg from baseline values, respectively) in relation to the control 
(+0.34 ± 1.58 kg) and the 16-h group (-0.64 ± 0.5 kg). In accordance with Klein, Sakurai, Romijn and 
Carroll (1993), a notable shift in substrate oxidation occurs between 18 and 24 hours of fasting, with 
a marked increase in the rate of fat oxidation and a decrease in glucose oxidation, which might 
explain the greater decrease in body fat by the 20-h and 24-h group. Interestingly, the 20-h group 
lost more body weight and body fat (3.65 ± 1.86 kg and 3.53 ± 2.94 kg, respectively) than the 24-h 
group (2.97 ±4.70, and -2.70± 4.88 kg, respectively). From food diary analyses it is possible to 
observe that the 20-h group was consuming less energy in relation to baseline values both in week 4 
and week 8 (energy restriction of 35 and 29%, respectively) than the 24-h group (energy restriction 
of 26 and 34%, respectively) which might explain the differences between the 20-h and 24-h group 
regarding body weight and body fat losses. However, it is unclear whether there are other reasons 
that may explain these differences, and due to the absence of blood samples collection and analysis, 
it is not possible to clarify whether these differences were due to metabolic adaptations or 
hormonal alterations that might occur in the human body between 20 and 24 hours of fasting. 
Furthermore, the lack of literature regarding the tracking of hormones every two to three hours 
during the first 24 hours of fasting is notable, making these results impossible for further 
clarification.  
The decrease in body weight indicates that participants were not compensating during the 
feeding period for the reduced energy intake during fasting periods, as observed by the food diary 
analyses. As a matter of fact, all the groups were experiencing some level of energy restriction, 
probably due to the knowledge of being a participant in a weight loss study. These results are 
opposite to the ones described in mice but in agreement with the ones stated by Klempel, Bhutani, 
Fitzgibbon, Freels and Varady (2010) in humans.  
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The mean energy restriction in week 4 and week 8 reveals a mean of 21% in the control, 21% 
in the 16-h, 32% in the 20-h and 30% in the 24-h group in relation to baseline values. Theoretically, if 
participants had kept the same energy restriction during the entire study, body weight would have 
decreased by 4.5 kg in the control, 4.5 kg in the 16-h, 6.3 kg in the 20-h and 4.8 kg in the 24-h group, 
which reveals a gap between the actual weight lost and the energy restriction reported, which have 
also been identified by Klempel et al. (2010).  
However, the equation which dictates that energy potential of body mass remains constant 
when caloric intake equals caloric expenditure (Change in energy stores = energy intake - energy 
expenditure) is only truth in closed systems and not in open systems, like the human body (McArdle, 
Katch, & Katch, 2009). Furthermore, different macronutrient distribution on a diet lead to different 
biochemical pathways and consequently to different rates of weight loss (Feinman & Fine, 2003). 
Therefore, the divergence observed between the actual weight loss and the energy restriction 
reported are more than just an underreporting case.  
Results from the food diaries also revealed that participants were able to keep energy intake 
during the fasting periods below 25% of energy requirements, as was instructed. Despite no 
significant differences being observed regarding energy intake between groups, a trend towards 
consuming more energy as the length of fasting increased was observed. Similar percentage of non 
compliant participants with the food diaries has also been observed by Klempel et al. (2010). 
One of the benefits attributed to IF regimes in relation to daily calorie restriction diets is the 
preservation of lean tissue, as evidenced by the low effect size reported in this study. Other studies 
have previously demonstrated this sparing effect in lean tissue (Bhutani, Klempel, Berger, & Varady, 
2010; Varady, 2011; Varady, et al., 2009).  
The decrease in body weight and in fat mass achieved by the 20-h group (5 ± 2% and 3.53 ± 
2.94 kg, respectively) does not agree with the values obtained by Soeters et al. (2009) and by 
Halberg et al. (2005), who did not find any significant differences in body weight and fat mass after 
two weeks of 20 hours of fasting on alternate days. However, it is important to highlight that these 
studies were not intended to achieve changes in body composition and that participants were 
instructed to consume food to maintain body weight. On the other hand, the changes in body weight 
and body fat mass experienced by the 20-h group were greater than the ones  reported in the study 
of Stote et al. (2007). The results reported by the 24-h group were similar to the ones described by 
Heilbronn et al. (2005). 
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No significant differences were observed in REE at any time, as previously shown by 
Heilbronn et al. (2005), however, a strong effect size regarding the impact of fasting on REE was 
observed. Nevertheless, it is important to point out that the face masks used to measure REE were 
all of the same size, being possibly too big for some participants, thus allowing room for air to 
escape, which could have negatively affected the measurement. 
This is the first study to appraise the impact of different lengths of fasting and feeding on 
body weight and body composition and to report its effects on REE.  
A key limitation of this study was the size of the sample which is too small to draw strong 
conclusions from the observed results. Despite this, some significant differences were observed, 
particularly in the 20-h group, which means that more investigation should be conducted in this 
field.   
In addition, the study was conducted during summer time, so most of the participants were 
on holiday, which may have introduced alterations in the normal routine of physical activity and 
eating patterns.  
Also, the alternate day regime was not accomplished by all the participants as evidenced by 
the food diary analyses, with the tendency to skip periods of fasting on Sundays, possibly because it 
is a day associated with family-time meals. 
 
Conclusion 
It is suggested by the data presented in this paper that IF regimes with a length of fasting of 
20 hours in alternate days are more efficient than true intermittent fasting protocols normally used 
(24 hours of fasting in alternate days). However, more research in this area is needed, specifically a 
similar design study using a bigger sample and one that involves the collection of blood samples 
from participants in order to achieve a better understanding of metabolic adaptations in response to 
different lengths of fasting.  
Furthermore, it appears to be extremely important to keep records of food intake during the 
entire length of the study, or at least, a record of the weekly number of fasting days accomplished. 
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Participant Information Sheet 
 
Intermittent Fasting: How long is enough? 
 
You are being invited to take part in a research project.  Before you decide, it is important that you 
understand why the research is being done and what it will involve. Please read the following 
information carefully and ask for clarification, if there is something that is not clear.  Take time to 
decide whether or not you wish to take part.  
 
What is the purpose of the study? 
Intermittent fasting is getting a lot of attention lately as a viable option to lose body weight and 
change body composition. The aim of this study is to determine if there are optimal fasting periods 
during intermittent fasting approaches.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form.  Even if you decide to take part on 
the study, you are free to withdraw at any time and without giving an explanation. 
 
What will happen to me if I take part? 
You will participate in a study lasting nine weeks, of which the first will be a control week and the 
following will be intervention weeks. In the control week, your height, body composition (total body 
weight, fat mass and fat free mass) and resting metabolic rate will be measured. This procedure will 
be repeated again at week four and week eight. In order for this to be possible, you will have to 
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come to University of Chester sports laboratory (on three different occasions, at the start, week four 
and week eight) after an overnight fast.  
During the eight weeks of intervention, you will have to do fast periods in alternate days, which 
length depend on the group where you were allocated: 
Group 1 - 8 hours of fast/16 hours of feeding everyday (overnight fast); 
Group 2 - 16 hours of fasting /8 hours of feeding in alternate days; 
Group 3 - 20 hours of fasting/4 hours of feeding in alternate days; 
Group 4 - 24 hours of fasting in alternate days; 
 
Allocation in groups will be made by matching criteria such as gender and body mass index. 
 
What are the possible disadvantages and risks of taking part? 
In some cases fasting periods can cause general tiredness, weakness, dizziness, headaches, stomach 
aches and in extreme events even fainting. In addition, you can suffer from stress and inadaptation 
due to  changes in your lifestyle caused by fasting periods. However, please rest assured that these 
side effects only occur in a few people and most people do not experience the extreme versions of 
these. You might need a couple of days to adjust to the fasting period. 
 
What are the possible benefits of taking part? 
It is expected that you will change your body composition mainly by decreasing body fat. If this 
happens, you will benefit from a series of improvements in health, which are characteristic of body 
fat loss, such as improving in lipid profile, less fatigue, more energy, etc.. 
You will also receive a detailed body composition analysis, as well as a nutritional analysis of your 
food intake. 
 
What if something goes wrong? 
If you feel concerned over any aspect about the way you have been approached or treated during 
the course of this study, you can contact Professor Sarah Andrew, Dean of the Faculty of Applied 
Sciences, University of Chester, Parkgate Road, Chester, CH1 4BJ, 01244  513055. 
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Will my taking part in the study be kept confidential? 
All information collected during the course of the research will be kept strictly confidential so that 
only the researcher carrying out the research will have access to it.   
Assessment in the laboratory is going to be individual and none of the measures will be revealed to 
anyone except yourself. 
In addition, to perform statistical analysis of the data, participants' names are going to be replaced 
by codes and thus, the researchers will have no knowledge of the connection between the codes 
and the real person. This step ensures the confidentiality of the data since these can not be 
associated with a name. 
 
What will happen to the results of the research study? 
The results will be written up into a dissertation as a final project from my MSc. Individuals who 
participate will not be identified in any subsequent report or publication. 
 
Who is organising the research? 
The research will be conducted as part of a MSc in Exercise & Nutrition Science within the 
Department of Clinical Sciences at the University of Chester. The study is organised with supervision 
from the department, by Andreia Filipa Luís de Castro, an MSc student. 
 
Who may I contact for further information? 
If you would like more information about the research before you decide whether or not you would 
be willing to take part, please contact: 
 
Name: Andreia Castro;  
Email: 1219680@chester.ac.uk 
 
Thank you for your interest in this research. 
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Intermittent Fasting: How long is enough? 
Consent Form 
 
            Please initial box 
 
1. I confirm that I have read and understand the information sheet  
     for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to  
     withdraw at any time, without giving any reason and without my  
     legal rights being affected. 
 
3. I agree to take part in the above study.    
 
 
 
 
___________________                _________________   _____________ 
Name of Participant Date  Signature 
 
 
 
Researcher Date Signature 
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Intermittent Fasting: How long is enough? 
Food Diary Instructions 
 
Write down everything you eat and drink over the day.  
Time: Write the time of day you ate the food and which meal it represents for you, i.e. breakfast, 
morning snack, dinner, etc. 
Description of food and/or drink: Write down the type of food and/or drinks you consumed. Give 
details and be as specific as you can, differentiating between foods of the same type but that are 
different in content, eg wholemeal vs. white bread or freshly squeezed orange juice vs. orange juice 
made from concentrate. Include information about the way that food was prepared, for example, 
fryed, boiled, baked and steamed. Don't forget to write down "extras," such as salad dressing, 
mayonnaise, butter, sugar and ketchup.  
Portion Size: Try to weigh and measure what you eat and drink. If you don’t have a scale for this, 
estimate the quantities using containers (1 cup, 1 mug, a level tea spoon or heaped cereal bowl) or 
use the food portion photographs that are attached to these instructions in order to describe 
portion sizes ( small, medium or large). If you have consumed a ready made meal, then attach the 
food label to your food diary for later analysis. 
Some basic rules to remember: 
 Try to be as honest as possible and record everything you eat and drink (remember that this 
information is confidential). 
 It's hard to remember what you've eaten at the end of the day, so try to record things as you 
go.  
 
Physical Activity: Write down the time and duration of exercise performed 
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Please use the following example as a guideline to a proper filling of your food diary. 
 
Time Description of food and/or drink Portion Size 
 
8 am 
Breakfast 
 
Rolled oats (microwaved with water) 
Cinnamon 
Frozen raspberries 
Honey 
Water 
40g 
 Teaspoon 
100g 
1 tablespoon 
1 glass 
11 am 
Morning 
snack 
 Red Apple 
Almonds 
Coffee 
Sugar 
Medium size 
10 units 
200 ml 
2 teaspoons 
 
 
1.30 pm 
Lunch 
Wholemeal bread 
Tuna in brine 
Cottage cheese 
Tomato 
Lettuce 
Water 
2 thick slices 
Small can 
2 tablespoons 
Small size 
1 leaf 
330 ml bottle 
4.30 pm 
Afternoon 
snack 
Fat free Greek yoghurt 
Almonds 
Coffee 
Sugar 
1 cup 
10 units 
200 ml 
2 teaspoons 
 
7 pm 
Dinner 
Basmati rice boiled 
Chicken breast roasted 
Broccoli steamed 
Olive oil 
Small portion 
Medium portion 
2 cups 
1 tablespoon 
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Intermittent Fasting: How long is enough? 
Food Diary 
Week: 
Monday 
Time Description of food and/or drink Portion Size 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
Physical Activity:  
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Food Portions Photographs 
Intermittent Fasting: How long is enough? 
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Adapted from:  EPIC/CNC study. Food Diary. Available at:  
 http://dapa-toolkit.mrc.ac.uk/documents/en/non/non-study_EPIC_diary.pdf 
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Intermittent Fasting: How long is enough? 
 
During your fasting period, If you feel weak, dizzy, or have headaches then please consume 
foods in small quantities. These foods may be from the following options.  
You will be provided with an individualised total amount of energy that you can consume 
from this list. This amount will be no more than 25% of your total energy requirements. 
 
Daily Energy Requirements: ________________ 
25% of Daily Energy Requirements: ________________ 
Food List 
Food Total Energy (Kcal) 
Fruit  
Apple (medium size) 70 
Banana (medium size) 120 
Pear (medium size) 60 
Avocado (medium size) 230 
Strawberries (10 medium units) 40 
Raspberries (20 units) 20 
Grapefruit (medium size) 100 
Tomato (medium size) 25 
Vegetable  
Lettuce (medium portion) 10 
Spring Onions (medium size) 5 
Cucumber (medium size) 24 
Celery (1 medium stalk) 6 
Beetroot (medium size) 45 
Legumes  
Baked beans (small can) 205 
Chickpeas (3 tbsp) 60 
Peas (3 tbsp) 45 
Cereals  
Oats (30g uncooked) 126 
Rice (100g cooked) 130 
Pasta (75g uncooked) 175 
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Bread (2 slices) 220 
Meat/ Fish/ Egg  
Tuna in Brine (canned) 140 
Egg 80 
Chicken breast (grilled) 145 
Nuts and dry fruits  
Raw/toasted Almonds (10 units) 60 
Raw/toasted Cashews (10 units) 55 
Raw/toasted Macadamia nuts (10 units) 200 
Walnuts (10 units) 260 
Pistachio (25 units) 80 
Pecan (10 units) 195 
Raisins (25 units) 40 
Apricots (5 units) 95 
Figs (5 units) 100 
Prunes (5 units) 210 
Cranberries (25 units) 123 
Drinks  
Almond milk -  unsweetened (250 mL) 35 
Soya milk  - unsweetened (250 mL) 70 
Dairy  
Semi-skimmed milk (250 mL) 150 
Skimmed milk ( 250 mL) 110 
Whole milk ( 250 mL) 200 
Yogurt Low Fat (125mL) 65 
Cheddar Cheese (1 slice) 110 
Cottage cheese – low fat (portion 28g) 24 
 
If the symptoms still persist after the consumption of these foods, then please contact the 
researcher on the following email address: 1219680@chester.ac.uk for further instructions. 
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Allocation in groups by BMI matching criteria 
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Allocation in groups by BMI matching criteria 
 
 
 
The highlighted cells represent the participants that have dropped out 
 
 
 
 
 
 
 
 
 
 
  
Control 16-h 20-h 24-h 
Gender BMI  
(kg/m2) 
Gender BMI 
 (kg/m2) 
Gender BMI  
(kg/m2) 
Gender BMI  
(kg/m2) 
Female 22.2 Female 22.9 Female 22.7 Female 22.3 
Male 24,1 Male 26.6 Male 26.2 Female 26.9 
Male 23.1 Female 23.1 Female 22.9 Female 22.8 
Female 30.3 Male 31.1 Female 30.5 Male 30.4 
Male 22.1 Female 20.9 Female 21.2 Female 21.0 
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Resting energy expenditure mean values at baseline, week 4 and week 8 in 
kilojoules 
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Resting energy expenditure mean values at baseline, week 4 and week 8 in kilojoules 
 
 
 
 
 
 
 
 
 
 
  
 Baseline Week 4 Week 8 
 Mean ± SD Mean ± SD Mean ± SD 
(kJ) (kJ) (kJ) 
Control (n=5) 6524 ± 1288 6840 ±2096 7180 ± 1860 
16-h (n=5) 6352 ± 3036 6824 ± 3832 7004 ± 2500 
20-h (n=4) 5916 ± 1352 4592 ± 1816 5012 ± 2008 
24-h (n=3) 6060 ± 2732 6608 ± 2172 6032 ± 2700 
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Daily energy requirements at baseline, week 4 assessment in kilojoules 
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Daily energy requirements at baseline, week 4 assessment in kilojoules 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Baseline Week 4 
DER 
(kJ) 
25% of DER 
(kJ) 
DER 
(kJ) 
25% of DER 
(kJ) 
     
Control (n=5) - - - - 
16-h (n=5) 10736 ± 3740 2684 ± 936 10504 ± 5936 2624 ± 1484 
20-h (n=4) 8896 ± 2076 2224 ± 520 7428 ±2640 1856 ± 660 
24-h (n=3) 9612 ± 3968 2404 ± 992 9896 ±3576 2476 ± 892 
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Appendix 9  
Mean energy intake at baseline, week 4 and week 8 in kilojoules 
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Mean energy intake at baseline, week 4 and week 8 in kilojoules 
 
 
Baseline Week 4 Week 8 
 
Mean  ± SD Mean  ± SD Mean  ± SD 
 
(kJ) (kJ) (kJ) 
Control (n=4) 75628 ± 12772 56064 ± 4376 64176 ± 14780 
16-h (n=3) 74384 ± 23144 59012 ± 9124 59848 ± 15060 
20-h (n=4) 68876 ± 14992 11182 ± 8952 48568 ± 14472 
24-h (n=3) 56208 ± 10804 41436 ± 8684 36840 ± 9696 
